SEC
HCAT icon

Seven Eight Capital’s Health Catalyst HCAT Stock Holding History

Seven Eight Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,300
Closed -$743K – 502
2020
Q3 		$743K Buy
+20,300
New +$689K 0.16% 242

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Seven Eight Capital's HCAT Position: Q4 2020 in Review

Seven Eight Capital sold out of Health Catalyst (HCAT) in Q4 2020, closing a stake of 20,300 shares — an estimated $743K sold.

Seven Eight Capital first reported a position in HCAT in Q3 2020 and held it in 1 quarter. The position peaked at $743K in Q3 2020. 168 funds tracked by Wall St. Rank hold HCAT as of Q4 2020.

  • Seven Eight Capital reported no remaining Health Catalyst position as of Q4 2020 after selling out during the quarter.
  • Seven Eight Capital sold 20,300 Health Catalyst shares in Q4 2020, an estimated $743K.
  • Seven Eight Capital first reported a position in Health Catalyst in Q3 2020 and held it in 1 quarter.
  • Seven Eight Capital's Health Catalyst position peaked at $743K in Q3 2020.
  • 168 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2020.

Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.